Why the study?
Does standard dose enoxaparin provide reliable anti-Xa activity for VTE prevention in critically ill multiple trauma patients?
Does standard dose enoxaparin provide reliable anti-Xa activity for VTE prevention in critically ill multiple trauma patients?
Standard VTE prophylaxis dosing of enoxaparin yields unpredictable anticoagulation levels in critically ill trauma patients, especially those with peripheral edema, suggesting a potential need for monitoring or dose adjustment.
Answers are grounded in this paper and cite their sources.
Standard enoxaparin dosing may yield unreliable anti-Xa activity in edematous trauma patients; leaves open whether monitoring or adjustment improves VTE prevention.
The standard dose of enoxaparin recommended for the prevention of VTE following multiple trauma provides unreliable and highly variable anti-Xa activity in critically ill trauma patients, and is strongly affected by the presence of significant peripheral edema.
No takes yet. Share an insight, caveat, or question.
Haas et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: